Aspiriant LLC’s ESAB ESAB Stock Holding History

Aspiriant LLC’s Portfolio ESAB Stock Details ESAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-2,666	Closed	-$263K	–	437
2026 Q2	$263K	Buy	2,666 +21	+0.8%	+$2.03K	0.01%	338
2026 Q1	$256K	Sell	2,645 -1,608	-38%	-$186K	0.01%	301
2025 Q4	$475K	Buy	4,253 +33	+0.8%	+$3.78K	0.01%	220
2025 Q3	$472K	Sell	4,220 -13	-0.3%	-$1.55K	0.01%	206
2025 Q2	$510K	Sell	4,233 -3	-0.1%	-$363	0.02%	196
2025 Q1	$493K	Buy	4,236 +16	+0.4%	+$1.95K	0.02%	191
2024 Q4	$506K	Hold	4,220	–	–	0.02%	188
2024 Q3	$449K	Sell	4,220 -4	-0.1%	-$396	0.02%	194
2024 Q2	$399K	Sell	4,224 -125	-3%	-$13K	0.02%	200
2024 Q1	$481K	Sell	4,349 -2	-0%	-$187	0.02%	203
2023 Q4	$377K	Sell	4,351 -6	-0.1%	-$455	0.02%	219
2023 Q3	$306K	Sell	4,357 -12	-0.3%	-$835	0.02%	220
2023 Q2	$291K	Hold	4,369	–	–	0.01%	227
2023 Q1	$258K	Hold	4,369	–	–	0.01%	234
2022 Q4	$205K	Buy	+4,369	New	+$183K	0.01%	260

Other funds holding ESAB

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

Fenimore Asset Management Cobleskill, New York $4.55B AUM 5.53% 1-Year Est. Return

Copeland Capital Management Conshohocken, Pennsylvania $4.34B AUM 17.52% 1-Year Est. Return

Defender Capital Charlotte, North Carolina $319M AUM 12.55% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return

Lincoln Capital Lincoln, Nebraska $570M AUM 10.88% 1-Year Est. Return

Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return

Quadrant Capital Group Cincinnati, Ohio $3.7B AUM 33.76% 1-Year Est. Return

Aspiriant LLC's ESAB Position: Q3 2026 in Review

Aspiriant LLC sold out of ESAB (ESAB) in Q3 2026, closing a stake of 2,666 shares — an estimated $263K sold.

Aspiriant LLC first reported a position in ESAB in Q4 2022 and held it in 15 quarters. The position peaked at $510K in Q2 2025. 40 funds tracked by Wall St. Rank hold ESAB as of Q3 2026.

Aspiriant LLC reported no remaining ESAB position as of Q3 2026 after selling out during the quarter.
Aspiriant LLC sold 2,666 ESAB shares in Q3 2026, an estimated $263K.
Aspiriant LLC first reported a position in ESAB in Q4 2022 and held it in 15 quarters.
Aspiriant LLC's ESAB position peaked at $510K in Q2 2025.
40 funds tracked by Wall St. Rank held ESAB as of Q3 2026.

Based on Aspiriant LLC's 13F filing for Q3 2026, filed 16 Oct 2026.